OCT 04, 2016 10:12 AM PDT

More Evidence that Cancer is Not a Matter of Bad Luck

WRITTEN BY: Xuan Pham

A controversial study last year rocked the foundation of cancer and health research, suggesting that cancer was merely just “bad luck.” Many people didn’t take keen to this notion that the fate of their health was seemingly out of their control. However, a new study challenges the claim of luck, giving hope that our cancer risks can be up to us to decide.

Image credit: Pixabay.comCancer is not the result of one singular mutation. Rather, it is a series of mutations that compound on one another in the worst possible way to derail normal biological processes. But where do the mutations come from in the first place?

As cells grow and divide, they make mistakes along the way. Most of the time, cells have extraordinary quality control measures that catch and correct these errors. In cases where the mistake is too great, the cell can self-destruct in order to prevent the mutations from carrying on to future generations. However, the proof-reading and error-checking is not perfect, not 100 percent. This is why we have such a diverse human population of varying traits, including risks for certain diseases like cancer.

If a mutation in a germ cell (that is, sperm or egg) gets through the cell’s quality control check, it will be inherited by the parent’s children. Still, other mutations are influenced by environmental and lifestyle exposures, such as smoking. But where is the line between random accidents and deliberate cause-and-effect?

The answer, according to a study published in early 2015, was that some organs’ propensity for cancer are simply due to “bad luck.” Published in Science, the study claimed that a significant portion of cancer types, including ovarian and pancreatic cancers, were due to accidental mutations in adult stem cells.

But do these “bad luck” mutations happen at a high enough rate to account for these cancer developments? A new study disputes this apparent claim.

The study, published in Nature, analyzed adult stem cells taken from various organs. The aim was to calculate the rate and patterns of DNA mutations that could account for the high cancer rates in these organs.

What they found was a steady rate of accumulation for DNA mutations, at an average of 40 mutations per year. "We were surprised to find roughly the same mutation rate in stem cells from organs with different cancer incidence," said Ruben van Boxtel, professor at the Department of Genetics at University Medical Center Utrecht in the Netherlands, and senior author of the study.
 


"This suggests that simply the gradual accumulation of more and more 'bad luck' DNA errors over time cannot explain the difference we see in cancer incidence - at least for some cancers,” he added.
So, it’s not a matter of throwing our hands in the air in regards to cancer risks. Lifestyle choices play a huge role in mutations. This isn’t to say that “bad luck” is not part of the story, it just may not play as big a role as previously thought.

"This new research by Dr. van Boxtel and his group is important because it provides actual measured data on the rate of DNA error accumulation in human stem cells for the first time, and shows that perhaps not as much cancer risk is down to this type of 'bad luck' process as has recently been suggested,” said Lara Bennet, science communication manager at Worldwide Cancer Research.

Additional sources: MNT

About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
MAR 19, 2020
Cancer
MAR 19, 2020
Declining death rates for melanoma
Fewer people are dying from melanoma in the United States, suggests new research from the Perlmutter Cancer Center at NY ...
MAR 14, 2020
Technology
MAR 14, 2020
Mass Cytometry Can Bring New Cancer Therapeutics
New technology may soon accelerate cancer therapeutic development. The revolutionary technique is called mass cytometry ...
APR 02, 2020
Cancer
APR 02, 2020
Diagnosing Cancer: SMOC2 and Thyroid Cancer
  Thyroid cancer is the most common of the endocrine cancers, with papillary thyroid carcinomas (PTCs) being the mo ...
APR 09, 2020
Cancer
APR 09, 2020
The Unexpected Anti-Cancer Effects of the Human Telomerase
The research to find effective treatments and diagnosing tools in the fight against cancer has led to a thorough investi ...
APR 07, 2020
Cancer
APR 07, 2020
Chemo drugs are leaking into our water
With cancer as the second leading cause of death globally, it comes as a surprise that we know very little up until now ...
APR 30, 2020
Cancer
APR 30, 2020
A New microRNA for the Cancer Fighting Toolkit
MiRNAs are small snippets of genetic information that regulate gene expression thought to be able to regulate up to 60% ...
Loading Comments...